Nykode Therapeutics ASA — Director's Dealing 2023

Oct 27, 2023

Nykode Therapeutics - Mandatory notification of acquisition of shares by primary insider

Nykode Therapeutics - Mandatory notification of acquisition of shares by primary insider

Oslo, Norway, October 27, 2023 - Primary insider Martin Nicklasson, Chair of the Board of Nykode Therapeutics ASA, has today acquired 20,000 shares in Nykode Therapeutics AS at a price of NOK 16.36 per share. Following the transaction, Martin Nicklasson holds 52,000 shares in Nykode Therapeutics ASA.

Please see further details in the attached document.